Showing results (1-10 of 93) with videos related to
Sort By:
Pageof 10
Current Pharmaceutical Design|June 23, 2007
Growth factor therapy in atherosclerotic disease-friend or foeImo E Hoefer, Leo Timmers, Jan J PiekMolecular Interventions|September 11, 2007
Microsomal prostaglandin E2 synthase: a safer target than cyclooxygenases?Leo Timmers, Gerard Pasterkamp, Dominique P V de KleijnCurrent Pharmaceutical Design|February 27, 2013
Taking risk prediction to the next level. Advances in biomarker research for atherosclerosisMarten Siemelink, Sander van der Laan, Leo Timmers, et al.American Journal of Physiology. Heart and Circulatory Physiology|October 19, 2010
Assessment of collateral artery function and growth in a pig model of stepwise coronary occlusionDaphne de Groot, Sebastian Grundmann, Leo Timmers, et al.Current Pharmaceutical Design|May 14, 2008
Bridging innate immunity and myocardial ischemia/reperfusion injury: the search for therapeutic targetsFatih Arslan, Dominique P V de Kleijn, Leo Timmers, et al.Cardiovascular Research|January 24, 2012
The innate immune response in reperfused myocardiumLeo Timmers, Gerard Pasterkamp, Vince C de Hoog, et al.International Journal of Molecular Sciences|December 3, 2020
Extracellular Vesicles in Diagnosing Chronic Coronary Syndromes the Bumpy Road to Clinical ImplementationMirthe Dekker, Farahnaz Waissi, Nathalie Timmerman, et al.Frontiers in Cardiovascular Medicine|December 17, 2020
Current Devices in Mitral Valve Replacement and Their Potential ComplicationsLivia Gheorghe, Jorn Brouwer, Dee Dee Wang, et al.Frontiers in Cardiovascular Medicine|November 5, 2019
Complications Following Percutaneous Mitral Valve RepairLivia Gheorghe, Alfonso Ielasi, Benno J W M Rensing, et al.Journal of Visualized Experiments : Jove|October 22, 2016
Primary Outcome Assessment in a Pig Model of Acute Myocardial InfarctionGuilielmus H J M Ellenbroek, Gerardus P J van Hout, Leo Timmers, et al.Pageof 10